| Net Cash Provided by (Used in) Operating Activities |
-106M |
USD |
+65.8% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
108M |
USD |
-68% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
191M |
shares |
+60.9% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.24M |
USD |
-92.1% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
216M |
USD |
+234% |
Q4 2024 |
FY 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
59.1M |
USD |
+230% |
Q1 2024 |
Q1 2024 |
| Additional Paid in Capital |
2.87B |
USD |
+66.2% |
Q4 2024 |
FY 2024 |
| Interest Expense |
200M |
USD |
+54.2% |
Q4 2024 |
FY 2024 |